Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe footer revision label changes from v3.6.5 to v3.6.6, representing a minor site maintenance update rather than a change to study content.SummaryDifference0.0%

- Check17 days agoChange DetectedSynopsis Link appears on the Study Details page. A new sponsor-related block shows Boehringer Ingelheim as the sponsor with a 'Helpful Links Provided by' label and the text 'Drug and device information, study documents, and helpful links'.SummaryDifference0.2%

- Check31 days agoChange DetectedA new revision tag Revision: v3.6.5 was added, replacing the previous Revision: v3.6.4. This indicates a minor update to the page template or system without changing the study details.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a new release or update to the page/template.SummaryDifference0.0%

- Check74 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.3, indicating a minor update to the page version rather than substantive changes to the study details.SummaryDifference0.0%

- Check89 days agoChange DetectedThe study page now shows recruitment is closed ('No longer looking for participants') and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study), while updating the Intervention/Treatment heading formatting and the revision tag to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.